活性增强剂:最近的研究进展和对疾病的洞察力
Junyou Zhang1,2,3, Qilin Wang1,2,3, Jiaxin Liu1,2,3
1School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Biology direct
|November 13, 2024
概括
基因增强剂精确地控制基因表达,对发育至关重要. 研究增强剂,包括它们的表观遗传标记和相互作用,为基因调节和潜在的疾病治疗提供了洞察力.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 精确的基因表达调节对于生物体的发育至关重要.
- 增强剂是控制基因转录模式的关键调控元素.
- 与疾病相关的突变通常发生在增强剂中,突出显示了它们的临床相关性.
研究的目的:
- 提供对增强器特征的全面概述.
- 探索高级测序和功能基因组学在增强器研究中的应用.
- 讨论增强剂在人类疾病中的作用及其治疗潜力.
主要方法:
- 对全基因组增强剂表征的高通量测序技术的审查.
- 对与增强功能相关的表观遗传修饰的分析.
- 检查增强剂转录和增强剂-促进剂相互作用.
主要成果:
- 增强剂表现出明显的表观遗传修饰,产生转录,并与促进剂相互作用.
- 高通量测序和功能基因组学是增强器分析的强大工具.
- 增强剂研究为理解基因调节和开发精确药物的基础.
结论:
- 了解增强器机制对于破译基因调节至关重要.
- 增强剂代表了新型疾病预防和治疗策略的有希望的目标.
- 对增强器功能的进一步研究将促进精准医学的发展.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Eukaryotic Transcription Activators
10.9K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.9K
RNA Polymerase II Accessory Proteins
9.1K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.1K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


